Though this study has faced much disputed over the years, scientists are still going through with their research to prove that the benefits may outweigh the drawbacks. According to Fox 8 Cleveland, the US Preventive Services Task Force published on Monday updated recommendations regarding aspirin. According to the new findings, taking low-dose aspirin daily may reduce the risk of cardiovascular disease and colon cancer.
However, these recommendations are restricted to the 50-59 age group who have a high risk of cardiovascular disease. These patients would witness a drop in their risk of heart attacks, strokes, and colon cancer if they took aspirin daily. As for people between 60 and 69, they may find benefits from aspirin as well, but they should consult with their physicians first in order to study the consequences. Also, the research doesn’t give enough evidence to the benefits regarding people younger than 50 and older than 69.
This is the first time the task force releases such recommendations for people between the age of 50 and 59. The last time they issued recommendations was in 2009, and since then, more evidence has emerged that has lead them to issue better recommendations. Furthermore, the 2009 study had been studying the different effects that this treatment would have on men and women; however, since then, the research has shown that men and women react to the treatment in the same manner.
Moreover, the task force stressed that this recommendation is not for people that have high risk of gastrointestinal bleeding, and it is for people that have 10 years life expectancy or more, and are willing to take aspirin daily for 10 years or more.
However, this year’s findings are by no means definitive. In 2015, a study published by the Annals of Internal Medicine found that the daily use of low-dose aspirin reduced the risk of colon cancer. However, another study published in the Journal of the American College of Cardiology in the very same year claimed that this ‘preventive measure’ actually increased the risk of serious problems, such as gastrointestinal bleeding and ulcers, by as much as 60% in the studied patients.
The scientists that issued the latest recommendation insist that the benefits outweigh the risks for men and women of age 50-59, with 10-year life expectancy, and more than 10% risk of cardiovascular disease. However, as both sides of the issue have been studied and shown to be true, people are advised to check with their physicians prior to starting this preventive measure in order to make sure they fit the category.